Zafeiropoulos Paraskevas, Nanos Panagiotis, Tsigkoulis Evangelos, Stefaniotou Maria
University Ophthalmology Clinic of Ioannina, Ioannina, Greece.
University Eye Clinic, Democritus University of Thrace, Alexandroupolis, Greece.
Case Rep Ophthalmol. 2014 Dec 10;5(3):451-4. doi: 10.1159/000370144. eCollection 2014 Sep-Dec.
We present a case of a 41-year-old female patient with progressive bilateral visual loss. On examination, her best corrected visual acuity (BCVA) in her right eye was 3/10 and her BCVA in her left eye was 2/10. Fundus and optical coherence tomography examination revealed severe bilateral macular edema. She had been diagnosed with breast cancer 6 years ago and was receiving tamoxifen at a dosage of 20 mg/day ever since. Tamoxifen therapy was discontinued, and the patient received 250 mg of acetazolamide three times a day for a period of 1 month. Both foveae regained their normal contour within 2 months, and her vision was restored to 10/10 BCVA 3 months later. To our knowledge, this is the first case reported where bilateral intraretinal macular edema is the only retinal manifestation in a patient on oral tamoxifen.
我们报告一例41岁女性患者,患有进行性双侧视力丧失。检查时,她右眼的最佳矫正视力(BCVA)为3/10,左眼的BCVA为2/10。眼底和光学相干断层扫描检查显示双侧严重黄斑水肿。她6年前被诊断出患有乳腺癌,此后一直以每天20毫克的剂量服用他莫昔芬。停用他莫昔芬治疗后,患者每天服用250毫克乙酰唑胺,持续1个月。两个月内两个黄斑中心凹恢复了正常形态,3个月后她的视力恢复到BCVA 10/10。据我们所知,这是第一例报告的口服他莫昔芬患者中双侧视网膜内黄斑水肿是唯一视网膜表现的病例。